Association of prehospitalization aspirin therapy and acute lung injury: Results of a multicenter international observational study of at-risk patients

Daryl J. Kor, Jason Erlich, Michelle Ng Gong, Michael Malinchoc, Rickey E. Carter, Ognjen Gajic, Daniel S. Talmor

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Objective: To evaluate the association between prehospitalization aspirin therapy and incident acute lung injury in a heterogeneous cohort of at-risk medical patients. Design: This is a secondary analysis of a prospective multicenter international cohort investigation. Setting: Multicenter observational study including 20 US hospitals and two hospitals in Turkey. Patients: Consecutive, adult, nonsurgical patients admitted to the hospital with at least one major risk factor for acute lung injury. Interventions: None. Measurements and Main Results: Baseline characteristics and acute lung injury risk factors/modifiers were identified. The presence of aspirin therapy and the propensity to receive this therapy were determined. The primary outcome was acute lung injury during hospitalization. Secondary outcomes included intensive care unit and hospital mortality and intensive care unit and hospital length of stay. Twenty-two hospitals enrolled 3855 at-risk patients over a 6-month period. Nine hundred seventy-six (25.3%) were receiving aspirin at the time of hospitalization. Two hundred forty (6.2%) patients developed acute lung injury. Univariate analysis noted a reduced incidence of acute lung injury in those receiving aspirin therapy (odds ratio [OR], 0.65; 95% confidence interval [CI], 0.46-0.90; p = .010). This association was attenuated in a stratified analysis based on deciles of aspirin propensity scores (Cochran-Mantel-Haenszel pooled OR, 0.70; 95% CI, 0.48-1.03; p = .072). Conclusions: After adjusting for the propensity to receive aspirin therapy, no statistically significant associations between prehospitalization aspirin therapy and acute lung injury were identified; however, a prospective clinical trial to further evaluate this association appears warranted.

Original languageEnglish (US)
Pages (from-to)2393-2400
Number of pages8
JournalCritical Care Medicine
Volume39
Issue number11
DOIs
StatePublished - Nov 2011

Fingerprint

Acute Lung Injury
Aspirin
Observational Studies
Therapeutics
Intensive Care Units
Length of Stay
Hospitalization
Odds Ratio
Confidence Intervals
Propensity Score
Hospital Mortality
Turkey
Multicenter Studies
Clinical Trials
Incidence

Keywords

  • acute lung injury
  • acute respiratory distress syndrome
  • aspirin
  • prevention

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Association of prehospitalization aspirin therapy and acute lung injury : Results of a multicenter international observational study of at-risk patients. / Kor, Daryl J.; Erlich, Jason; Gong, Michelle Ng; Malinchoc, Michael; Carter, Rickey E.; Gajic, Ognjen; Talmor, Daniel S.

In: Critical Care Medicine, Vol. 39, No. 11, 11.2011, p. 2393-2400.

Research output: Contribution to journalArticle

Kor, Daryl J. ; Erlich, Jason ; Gong, Michelle Ng ; Malinchoc, Michael ; Carter, Rickey E. ; Gajic, Ognjen ; Talmor, Daniel S. / Association of prehospitalization aspirin therapy and acute lung injury : Results of a multicenter international observational study of at-risk patients. In: Critical Care Medicine. 2011 ; Vol. 39, No. 11. pp. 2393-2400.
@article{ab7a8829cb4c46debecd410963d3a350,
title = "Association of prehospitalization aspirin therapy and acute lung injury: Results of a multicenter international observational study of at-risk patients",
abstract = "Objective: To evaluate the association between prehospitalization aspirin therapy and incident acute lung injury in a heterogeneous cohort of at-risk medical patients. Design: This is a secondary analysis of a prospective multicenter international cohort investigation. Setting: Multicenter observational study including 20 US hospitals and two hospitals in Turkey. Patients: Consecutive, adult, nonsurgical patients admitted to the hospital with at least one major risk factor for acute lung injury. Interventions: None. Measurements and Main Results: Baseline characteristics and acute lung injury risk factors/modifiers were identified. The presence of aspirin therapy and the propensity to receive this therapy were determined. The primary outcome was acute lung injury during hospitalization. Secondary outcomes included intensive care unit and hospital mortality and intensive care unit and hospital length of stay. Twenty-two hospitals enrolled 3855 at-risk patients over a 6-month period. Nine hundred seventy-six (25.3{\%}) were receiving aspirin at the time of hospitalization. Two hundred forty (6.2{\%}) patients developed acute lung injury. Univariate analysis noted a reduced incidence of acute lung injury in those receiving aspirin therapy (odds ratio [OR], 0.65; 95{\%} confidence interval [CI], 0.46-0.90; p = .010). This association was attenuated in a stratified analysis based on deciles of aspirin propensity scores (Cochran-Mantel-Haenszel pooled OR, 0.70; 95{\%} CI, 0.48-1.03; p = .072). Conclusions: After adjusting for the propensity to receive aspirin therapy, no statistically significant associations between prehospitalization aspirin therapy and acute lung injury were identified; however, a prospective clinical trial to further evaluate this association appears warranted.",
keywords = "acute lung injury, acute respiratory distress syndrome, aspirin, prevention",
author = "Kor, {Daryl J.} and Jason Erlich and Gong, {Michelle Ng} and Michael Malinchoc and Carter, {Rickey E.} and Ognjen Gajic and Talmor, {Daniel S.}",
year = "2011",
month = "11",
doi = "10.1097/CCM.0b013e318225757f",
language = "English (US)",
volume = "39",
pages = "2393--2400",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Association of prehospitalization aspirin therapy and acute lung injury

T2 - Results of a multicenter international observational study of at-risk patients

AU - Kor, Daryl J.

AU - Erlich, Jason

AU - Gong, Michelle Ng

AU - Malinchoc, Michael

AU - Carter, Rickey E.

AU - Gajic, Ognjen

AU - Talmor, Daniel S.

PY - 2011/11

Y1 - 2011/11

N2 - Objective: To evaluate the association between prehospitalization aspirin therapy and incident acute lung injury in a heterogeneous cohort of at-risk medical patients. Design: This is a secondary analysis of a prospective multicenter international cohort investigation. Setting: Multicenter observational study including 20 US hospitals and two hospitals in Turkey. Patients: Consecutive, adult, nonsurgical patients admitted to the hospital with at least one major risk factor for acute lung injury. Interventions: None. Measurements and Main Results: Baseline characteristics and acute lung injury risk factors/modifiers were identified. The presence of aspirin therapy and the propensity to receive this therapy were determined. The primary outcome was acute lung injury during hospitalization. Secondary outcomes included intensive care unit and hospital mortality and intensive care unit and hospital length of stay. Twenty-two hospitals enrolled 3855 at-risk patients over a 6-month period. Nine hundred seventy-six (25.3%) were receiving aspirin at the time of hospitalization. Two hundred forty (6.2%) patients developed acute lung injury. Univariate analysis noted a reduced incidence of acute lung injury in those receiving aspirin therapy (odds ratio [OR], 0.65; 95% confidence interval [CI], 0.46-0.90; p = .010). This association was attenuated in a stratified analysis based on deciles of aspirin propensity scores (Cochran-Mantel-Haenszel pooled OR, 0.70; 95% CI, 0.48-1.03; p = .072). Conclusions: After adjusting for the propensity to receive aspirin therapy, no statistically significant associations between prehospitalization aspirin therapy and acute lung injury were identified; however, a prospective clinical trial to further evaluate this association appears warranted.

AB - Objective: To evaluate the association between prehospitalization aspirin therapy and incident acute lung injury in a heterogeneous cohort of at-risk medical patients. Design: This is a secondary analysis of a prospective multicenter international cohort investigation. Setting: Multicenter observational study including 20 US hospitals and two hospitals in Turkey. Patients: Consecutive, adult, nonsurgical patients admitted to the hospital with at least one major risk factor for acute lung injury. Interventions: None. Measurements and Main Results: Baseline characteristics and acute lung injury risk factors/modifiers were identified. The presence of aspirin therapy and the propensity to receive this therapy were determined. The primary outcome was acute lung injury during hospitalization. Secondary outcomes included intensive care unit and hospital mortality and intensive care unit and hospital length of stay. Twenty-two hospitals enrolled 3855 at-risk patients over a 6-month period. Nine hundred seventy-six (25.3%) were receiving aspirin at the time of hospitalization. Two hundred forty (6.2%) patients developed acute lung injury. Univariate analysis noted a reduced incidence of acute lung injury in those receiving aspirin therapy (odds ratio [OR], 0.65; 95% confidence interval [CI], 0.46-0.90; p = .010). This association was attenuated in a stratified analysis based on deciles of aspirin propensity scores (Cochran-Mantel-Haenszel pooled OR, 0.70; 95% CI, 0.48-1.03; p = .072). Conclusions: After adjusting for the propensity to receive aspirin therapy, no statistically significant associations between prehospitalization aspirin therapy and acute lung injury were identified; however, a prospective clinical trial to further evaluate this association appears warranted.

KW - acute lung injury

KW - acute respiratory distress syndrome

KW - aspirin

KW - prevention

UR - http://www.scopus.com/inward/record.url?scp=80054951233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054951233&partnerID=8YFLogxK

U2 - 10.1097/CCM.0b013e318225757f

DO - 10.1097/CCM.0b013e318225757f

M3 - Article

C2 - 21725238

AN - SCOPUS:80054951233

VL - 39

SP - 2393

EP - 2400

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 11

ER -